Updates
** Shares of medical device maker Abbott ABT.N rise 5.4% to $133.05
** ABT is the top performer on the S&P 500 .SPX index on Wednesday
** Stock has its best day since April 2023, if gains hold
** ABT, in a conference call, says it doesn't expect any tariff impact in Q2
** Impact of tariffs is projected to be a few hundred million dollars in 2025 - company
** ABT reaffirms its annual profit per share forecast of between $5.05 and $5.25, but beats Q1 earnings estimate
** Company says two new manufacturing and R&D investments in Illinois and Texas, totaling $500 million, are projected to go live by the end of 2025
** Up to last close, stock up 11.6% YTD
(Reporting by Sriparna Roy and Puyaan Singh in Bengaluru)
((Sriparna.Roy@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。